Earnings Insights · Axon Enterprise (AXON) · Q3 FY2026
Axon Enterprise (AXON) Q3 FY2026: Axon Q3 2026 Earnings: Software Growth Accelerates, but Federal Dedrone Delays Cut Outlook
By AlgovestIQ ResearchPublished
Read Axon Enterprise’s results announcement (Form 8-K, filed Nov 5, 2026)
Key earnings findings
Axon Enterprise (AXON) Q3 FY2026 · results discussed on the earnings call · Form 8-K filed
- Axon Enterprise reported Q3 FY2026 revenue of $908.6M against the $934.3M analyst estimate, 2.8% below it, and EPS of $1.72 against the $1.89 analyst estimate, 9.0% below it.
- However, Axon reduced its full-year revenue outlook after excluding approximately $130M of expected Federal Dedrone deployment revenue, highlighting that larger hardware-heavy projects are adding more timing volatility to results.
- AXON closed at $313.00 on Nov 6, 2026, down 18.2% from $382.56 on Nov 5, 2026, the last close before the results were released.
Sources: Axon Enterprise results announcement (SEC), the Q3 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references
Did Axon Enterprise beat earnings expectations?
- Revenue surprise across the last 8 reported quarters has ranged from -2.8% to 5.4%.
Reported figures against analyst estimates, compiled from AlgovestIQ data.
Axon Enterprise reported Q3 revenue of $908.6M, up 28% year over year, while GAAP diluted EPS improved to $0.68 from a loss of $0.03 a year earlier. Non-GAAP diluted EPS rose to $1.72 from $1.24, and Adjusted EBITDA increased 33% to $235.7M.
The quarter reinforced the acceleration of Axon’s software business and the growing contribution from newer offerings such as AI, real-time operations, records, 911 and counter-drone software. However, Axon reduced its full-year revenue outlook after excluding approximately $130M of expected Federal Dedrone deployment revenue, highlighting that larger hardware-heavy projects are adding more timing volatility to results.
Earnings Snapshot
| Metric | Reported | Change |
|---|---|---|
| Revenue | $908.6M | Up 28% YoY |
| GAAP net income | $57.0M | Versus $(2.2)M loss |
| GAAP diluted EPS | $0.68 | Versus $(0.03) |
| Non-GAAP net income | $143.5M | Up from $102.7M |
| Non-GAAP diluted EPS | $1.72 | Up from $1.24 |
| Adjusted EBITDA | $235.7M | Up 33% YoY |
| Adjusted EBITDA margin | 25.9% | Up from 24.9% |
| Gross margin | 56.7% | Down from 60.1% |
| Adjusted gross margin | 59.2% | Down from 62.7% |
| Operating cash flow | $19.7M | Down from $60.0M |
| Free cash flow | $(18.9)M | Versus $33.4M inflow |
| Software & Services revenue | $437.0M | Up 43% YoY |
| Connected Devices revenue | $471.5M | Up 16% YoY |
| Annual recurring revenue | $1.75B | Up 40% YoY |
| Net revenue retention | 126% | Up from 124% |
| Future contracted bookings | $15.8B | Up 39% YoY |
The Bigger Story
Axon’s investment case is increasingly centered on whether its expanding public-safety platform can sustain high growth while managing the lower-margin, more volatile hardware mix required to enter newer markets.
The company announced a $1.2B additional investment in Skydio, increasing Axon’s fully diluted ownership stake to 37%, alongside an exclusive U.S. and Canadian public-safety distribution agreement. Management views drones, counter-drone systems, real-time operations software and AI tools as interconnected components of a larger public-safety platform rather than stand-alone products.
The Skydio arrangement broadens Axon’s position in Drone as First Responder deployments, while Dedrone provides counter-drone capabilities. Still, the economic model differs from Axon’s core software business: Skydio distribution revenue will be recognized on a net basis within Software & Services, reflecting Axon’s channel margin rather than the customer’s full purchase price.
More immediately, the company’s revised outlook shows the trade-off in its push into Federal counter-drone deployments. Three delayed Federal Dedrone projects represented approximately $200M of bookings and $130M of revenue previously expected during the second half of 2026. The demand opportunity appears intact, but procurement, site preparation, delivery, acceptance testing and other deployment requirements can delay recognition of large individual contracts.
Revenue and Operating Performance
Software & Services was the standout in Q3. Revenue rose 43% year over year to $437.0M, accelerating from 35% growth in the prior quarter and approaching half of total company revenue.
Management attributed the growth to a larger installed user base and greater adoption of premium offerings, including the AI Era Plan, real-time operations, Axon Records, Axon 911 and Dedrone software. These newer software offerings collectively reached an annual revenue run rate of nearly $500M, more than double the prior-year level. AI annual recurring revenue exceeded $100M.
Annual recurring revenue increased 40% year over year to $1.75B, while net revenue retention held at 126%. That retention rate indicates continued expansion within existing customer accounts, although it excludes hardware subscription revenue and is normalized for phased deployments.
Connected Devices revenue increased 16% to $471.5M, but declined 6.9% sequentially. Platform Solutions was the major growth driver, rising 106% year over year to $125.0M, primarily reflecting Dedrone. Personal Sensors revenue increased to $113.5M from $106.7M a year earlier, while TASER revenue declined modestly to $233.0M from $238.0M.
The company said lower TASER 7 volume contributed to the decline in TASER revenue, while TASER 10 demand remains solid. Management expects the TASER category to resume growth in Q4 and sees the newly introduced TASER Ion as a potential way to reach users and use cases where conventional device form factors are less practical.
The approximately $30M Federal Dedrone deployment originally expected in Q3 would have lifted Connected Devices growth. Management emphasized that the delayed projects do not reflect a weaker demand environment, but rather the complexity and timing sensitivity of larger Federal deployments.
Profitability and Margins
Axon moved back to GAAP profitability at the operating level, reporting operating income of $42.1M versus an operating loss of $2.1M a year earlier. GAAP net income reached $57.0M, although the result included $59.5M of other income, principally related to strategic investments and marketable securities.
Adjusted EBITDA rose to $235.7M, producing a 25.9% margin, compared with 24.9% in the prior-year quarter. The result reflects operating leverage from higher revenue and a greater contribution from Software & Services.
Gross margin moved in the opposite direction. Reported gross margin declined 340 basis points year over year to 56.7%, while adjusted gross margin fell 350 basis points to 59.2%.
Connected Devices was the principal source of pressure. Its gross margin fell to 43.0% from 49.9%, reflecting a higher mix of counter-drone equipment and increased memory costs. The absence of global tariff refunds recognized in Q2 also weighed on sequential margins.
Software & Services maintained substantially higher margins, with a 71.4% gross margin, but that was down from 73.8% a year ago. Management cited the scaling of newer offerings and a larger professional-services mix. Software-only gross margin remained above 80%.
Management expects memory costs to create roughly 50 basis points of consolidated adjusted EBITDA headwind in 2026, with the largest impact in Q4. Its current planning assumption is that elevated memory costs remain a headwind through 2027 and 2028, although the company does not assume prices continue rising materially from current levels. Axon plans to offset some of that pressure through product pricing, software mix and operating-expense leverage.
Demand, Customers and Pricing
Five-year normalized bookings rose 25% year to date. Management said bookings across Dedrone, Axon 911, Fusus and AI more than doubled from the prior year and exceeded $1B year to date.
Future contracted bookings increased 39% year over year to $15.8B. Axon expects to fulfill approximately 20% to 25% of that balance over the next 12 months, with most of the remainder generally expected over the subsequent 10 years. This metric includes contracts with termination, cancellation and other clauses, as well as third-party agent arrangements where Axon may recognize only a net revenue amount.
The quarter included several large multiyear wins, including a $258M AI Era Plan and body-camera expansion with a state Department of Corrections, a $115M agreement with another state Department of Corrections, and a $40M package involving OSP 10 Premium, AI Era Plan and Axon Fusus with a major metropolitan police department.
Corrections, international and Federal markets are becoming more important sources of growth. International bookings increased more than 30% year to date, according to management, while Federal bookings increased more than fivefold. The latter is also where execution risk is highest, given larger counter-drone projects and more complex procurement and deployment requirements.
What is Axon’s guidance for Q4 and full-year 2026?
For Q4 2026, Axon expects:
- Revenue of $990M to $1.01B
- Adjusted EBITDA of $245M to $250M
The Q4 revenue range excludes two Federal Dedrone deployments totaling approximately $100M. Together with the $30M deployment deferred from Q3, the three delayed projects reduced the company’s 2026 revenue outlook by approximately $130M.
For full-year 2026, Axon expects:
- Revenue of approximately $3.61B to $3.63B, representing approximately 30% growth
- Adjusted EBITDA of $924M to $929M
- Adjusted EBITDA margin of approximately 25.6%
- Free cash flow of $350M to $400M
- Stock-based compensation expense of approximately $570M to $600M
- CapEx of $130M to $150M
The free-cash-flow outlook was reduced from a prior $450M target because Axon is accelerating inventory purchases. Management expects strategic inventory investment to consume $225M of cash during 2026 and to moderate after Q1 2027.
Balance Sheet, Cash Flow and Capital
Axon ended Q3 with $1.7B in cash, cash equivalents and short-term investments, against $2.9B of outstanding convertible and senior notes. Net debt was approximately $1.2B, up $182M sequentially.
The company raised $1.15B through the issuance of notes during the quarter. Management said the proceeds will strengthen liquidity and fund part of the Skydio investment. The $1.2B Skydio transaction is expected to be funded approximately 60% with cash and 40% with stock.
Operating cash flow declined to $19.7M from $60.0M a year earlier, while free cash flow was negative $18.9M. The main driver was a $93.0M increase in inventory during the quarter, including roughly $100M of strategic inventory investment intended to support product availability and reduce supply-chain risk.
Management expects inventory spending to continue into Q1 and potentially early Q2 2027 before normalizing. It expects free-cash-flow conversion to improve in 2027 but not return to its long-term 60% Adjusted EBITDA conversion target until 2028.
What Investors Should Watch
1. Federal Dedrone deployment timing
The $130M removed from 2026 expectations is the clearest near-term swing factor. Recognition of these deployments would support future growth, but their timing depends on procurement, site readiness, installation, acceptance testing and other operational steps.
2. Software mix and recurring revenue growth
Software & Services grew 43%, ARR reached $1.75B and net revenue retention remained 126%. Sustained growth in AI, records, 911 and real-time operations would help offset lower-margin hardware mix and support long-term profitability.
3. Gross-margin pressure from hardware and memory costs
Counter-drone equipment, higher memory costs and newer product categories reduced gross margin. Investors should watch whether software growth, pricing actions and scale can contain these pressures through 2027 and 2028.
4. Skydio execution and capital allocation
The Skydio investment expands Axon’s strategic position in drones but adds capital requirements and execution complexity. The key test will be whether Axon can translate exclusive public-safety distribution into profitable channel revenue and broader platform adoption.
5. Free-cash-flow normalization
The inventory strategy may strengthen product availability, but it has materially reduced near-term cash conversion. Inventory levels, working capital and the pace of free-cash-flow recovery will matter as the company operates with a larger debt balance.
AlgovestIQ Takeaway
Axon’s Q3 results were fundamentally strong, led by an accelerating software business that is becoming a larger part of revenue. The company’s recurring-revenue metrics, bookings growth and large customer wins support management’s view that demand remains broad across public safety, corrections, Federal, international and enterprise markets.
The central complication is that Axon is becoming less predictable at the margin as counter-drone projects grow larger. Delayed Federal Dedrone deployments reduced full-year revenue expectations by $130M, and the company is appropriately signaling that these hardware-heavy projects can shift reported growth between quarters.
Profitability remains solid on an adjusted basis, but gross-margin pressure is real. The growing software mix is favorable, yet counter-drone hardware and elevated memory costs are lowering margins in the near term. Axon’s ability to preserve Adjusted EBITDA margins will depend increasingly on operating leverage, product pricing and continued software adoption.
The Skydio partnership could deepen Axon’s role in the public-safety drone ecosystem, but it also marks a larger capital commitment and raises the importance of execution outside Axon’s traditional core. The investment case now rests on whether the company can convert its expanding platform, contracted demand and strategic drone position into durable growth without allowing hardware volatility, working-capital investment and margin pressure to dilute the economic benefits of that expansion.
How did AXON stock react?
AXON closed at $313.00 on Nov 6, 2026, down 18.2% from $382.56 on Nov 5, 2026, the last close before the results were released.
| Session | Close | Change |
|---|---|---|
| Nov 5, 2026 (before release) | $382.56 | — |
| Nov 6, 2026 | $313.00 | -18.2% |
Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.
More from this earnings season
- RDWRedwire Q3 2026 Earnings: Record Margins and Backlog Offset Uneven Revenue TimingNov 5, 2026
- RKLBRocket Lab Q3 2026 Earnings: Backlog Jumps to $3.6B as Neutron Demand Supports Higher Launch PricingNov 9, 2026
- ACHRArcher Aviation Q3 2026 Earnings: FAA Authorization Advances Los Angeles Air-Taxi PlansNov 9, 2026
- GDGeneral Dynamics Q3 2026 Earnings: Record Submarine Awards Double Backlog as Guidance RisesOct 30, 2026
- LUNRIntuitive Machines Q3 2026 Earnings: Record Revenue and Backlog, but Cash Generation Relied on Working Capital and Equity IssuanceNov 12, 2026
References
- Management commentary, analyst questions and outlook discussed on the call. Source: Axon Enterprise Q3 FY2026 earnings call transcript, as of Nov 5, 2026.
- Reported results, segment figures and guidance from the company's results announcement. Source: Axon Enterprise Form 8-K, Item 2.02 (SEC EDGAR), as of Nov 5, 2026.
- Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Nov 5, 2026.
AI-generated analysis based on company-reported earnings data and earnings-call materials. Every reported figure is checked against Axon Enterprise's earnings release and call transcript before publication. Not investment advice.